DeviceSpace (Free subscription) | 11/05/2009
() Announces Record Revenue of $20 Million for Second Quarter of Fiscal 2010 11/5/2009 DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced second quarter fiscal 2010 revenue of $20 million.
Business Wire (Free subscription) | 11/05/2009
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced second quarter fiscal 2010 revenue of $20 million. Recent financial and operating highlights during the second quarter of fiscal 2010 include: U.S. commercial Impella revenue totaled $12.1 million, up 95% compared to revenue of $6.2 million in the...
Business Wire (Free subscription) | 10/28/2009
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, November 5, 2009, the Company will release financial results for the second quarter of fiscal 2010. The Company will host a conference call to discuss the results on Thursday, November 5, 2009, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L....
StreetInsider.com News Articles (Free subscription) | 11/04/2009
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before Market Opens: Economics: 8:30am ET Employment Cost Index - no Street consensus Initial jobless claims - Street Sees 520K Continuing Claims - Street Sees 5.75M Earnings: Abiomed, Inc. (NASDAQ: ABMD) – consensus loss $0.21 Abraxis BioScience, Inc. (NASDAQ: ABII) –...
